Although significant progress has been made in the field, the molecular mechanisms by which RANK, RANKL, and OPG modulate cardiovascular diseases, heart failure and to some extent hemostasis remain unclear and need further investigation. Here, TNFRSF11B is linked to cardiovascular disorder.